Helping Spanish-speaking patients manage high-risk drinking days with mobile treatment
Official title: Targeting High Risk Drinking Days with Mobile Treatment for Spanish-Speaking Patients
Funded at Yale University · NIH-10896435 · Data updated 2026-11-12
This study is creating a helpful mobile program for Spanish-speaking people who want to cut back on drinking, offering support right when they need it most, using easy-to-understand techniques that fit their culture.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $175,714 |
| NIH project number | 5K99AA031032-02 |
| Project ID | NIH-10896435 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Spanish-speaking individuals aged 21 and older who experience high-risk drinking behaviors.
✕Less likely to help
Patients who do not speak Spanish or who do not engage in high-risk drinking behaviors may not benefit from this research.
What this research studies
This research aims to develop a mobile treatment program specifically designed for Spanish-speaking individuals who struggle with high-risk drinking days. By utilizing culturally adapted cognitive behavioral therapy (CBT) techniques delivered through mobile technology, the program seeks to provide immediate support during critical moments when individuals may be tempted to drink excessively. The approach focuses on overcoming barriers to treatment access, such as language and cultural differences, to improve outcomes for this underserved population. Participants will engage with the program during peak drinking times, allowing for timely intervention and support.
Why it matters
Potential benefit: If successful, this research could significantly reduce harmful alcohol consumption among Spanish-speaking patients by providing accessible and culturally relevant treatment options.
How similar studies have gone: Previous studies have shown success with similar mobile treatment approaches for substance use disorders, particularly in English-speaking populations, indicating potential for effectiveness in Spanish-speaking communities as well.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Benitez, Bryan — Yale University
- Study coordinator: Benitez, Bryan
Related research
Other NIH-funded projects on the same topics.
-
Aging Well with HIV: Alcohol, Risk Reduction, and Education Center (AWAR3E)
A center at Yale is exploring how aging with HIV interacts with alcohol use to create inflammation and frailty, with the goal of finding biomarkers and potential treatments.
-
Community Health Worker–Led Hypertension Prevention and Control in Nepal
A community health worker–driven approach in Nepal aims to prevent and control high blood pressure among adults by bringing education and care directly to communities and homes.
-
Community health worker-led hypertension prevention and control in Nepal
A community health worker–led program in Nepal aims to help adults prevent and better control high blood pressure through home visits, education, and ongoing support.
-
Adapting a mobile health tool to boost HIV outcomes for older adults with HIV in Ukraine
A mobile health platform called PositiveLinks would be adapted for older adults with HIV in Ukraine to help them stay engaged in care and improve treatment success.
-
Behavioral and neural links between spoken language sounds and written words in young children
This grant studies how young children learn from listening and reading to improve literacy, by looking at how sound patterns transfer to written language.
-
Understanding how autoimmunity causes myasthenia gravis
This project looks at why the immune system attacks the nerve-muscle connection in myasthenia gravis and how different patient groups are affected.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.